Shenzhen Kangtai Biological Products Co Ltd

Common Name
BioKangtai
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,913
Ticker
300601
Exchange
SHENZHEN STOCK EXCHANGE
Description
Shenzhen Kangtai Biological Products Co., Ltd. is a prominent pharmaceutical company specializing in the research, development, production, and sale of biopharmaceutical products and vaccines. As a si...

BioKangtai's GHG Emissions Data Preview

In 2023, BioKangtai completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, BioKangtai has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind BioKangtai’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore BioKangtai’s data sources below and access millions more through our Disclosure Search.

a. BioKangtai's Sustainability Report 2023
a. BioKangtai's Sustainability Report 2023

Insights into BioKangtai's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of BioKangtai amounted to 105,117 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of BioKangtai increased by 15.49%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

BioKangtai's Scope 1 Emissions Over Time

20212022202304 k8 k12 k16 ktCO2e-19%+136%
  • Total Scope 1
  • Year-over-Year Change

What are BioKangtai's Scope 1 emissions?

In 2023, the total Scope 1 emissions of BioKangtai were 15,952 metric tons of CO₂ equivalent (tCO₂e). a

Has BioKangtai reduced its Scope 1 emissions over time?

Since 2021, BioKangtai's Scope 1 emissions have increased by 91.59%, reflecting a rising long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2022), BioKangtai's Scope 1 emissions increased by 135.77%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are BioKangtai's Scope 2 emissions?

In 2023, BioKangtai reported Scope 2 greenhouse gas (GHG) emissions of 89,165 tCO₂e without specifying the calculation method. a

Has BioKangtai reduced its Scope 2 emissions over time?

Since 2021, BioKangtai's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 36.48%, reflecting a rising long-term trend in Scope 2 emissions over time. a

Compared to the previous year (2022), BioKangtai's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that BioKangtai 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does BioKangtai use for Scope 2 reporting?

In 2023, BioKangtai reported its Scope 2 emissions using an unspecified methodology. a

BioKangtai's Scope 2 Emissions Over Time

202120222023025 k50 k75 k100 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into BioKangtai’s GHG Emissions Intensity Compared to Industry Peers

In 2023, BioKangtai reported Scope 1 greenhouse gas (GHG) emissions of 15,952 tCO₂e and total revenues of USD 489 millions. This translates into an emissions intensity of 32.6 tCO₂e per millions USD. a

BioKangtai's Scope 1 Emissions Intensity Compared to Peers

102002,00050,000500,000Scope 1 Emissions (tCO2e)5502002,00010,000Revenues (Millions of USD)CCHPDSDCCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MHumanwell Healthcare GroupYear: 2023Scope 1: 23,403 tCO2eRevenue: $M 3,451Scope 1 Intensity: 6.78 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MHHHuadong MedicineYear: 2023Scope 1: 14,289 tCO2eRevenue: $M 5,716Scope 1 Intensity: 2.50 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYunnan Baiyao GroupYear: 2023Scope 1: 28,983 tCO2eRevenue: $M 5,503Scope 1 Intensity: 5.27 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MMGI TechYear: 2023Scope 1: 18 tCO2eRevenue: $M 409Scope 1 Intensity: 0.04 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MYuwellYear: 2023Scope 1: 2,201 tCO2eRevenue: $M 1,122Scope 1 Intensity: 1.96 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$M

How does BioKangtai's GHG emissions intensity compare to its peers?

In 2023, BioKangtai reported a Scope 1 emissions intensity of 32.6 tCO₂e per millions USD. Compared to the peer group median of 23.6 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does BioKangtai rank on GHG emissions intensity within its industry?

In 2023, BioKangtai ranked 17 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

BioKangtai is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to BioKangtai's GHG Emissions Dataset?
Sign Up